A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, ...

Hyperfine, Inc., creators of the world’s first portable magnetic resonance imaging device, has named Neela Paykel as General Counsel and Tom Teisseyre as Chief Product Officer, continuing its ...

A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.'s corporate website at https://investors.hyperfine.io/. Participants are encouraged ...

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality This major Swoop® system scanner redesign and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

GUILFORD, Conn., Dec. 13, 2021 /PRNewswire/ -- Hyperfine Inc., creator of Swoop ®, the first FDA-cleared portable magnetic resonance imaging™ (MRI) device, today announced the Board of Directors that ...

GUILFORD, Conn., Oct. 28, 2021 /PRNewswire/ -- Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced the appointment of Scott ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...

Hyperfine, Inc. (NASDAQ:HYPR) shareholders should be happy to see the share price up 19% in the last month. But that doesn't change the fact that the returns over the last half decade have been ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic ...

The Swoop system tackles a critical challenge in health care, limited access to affordable and prompt brain imaging. More than three billion people globally are affected by brain diseases, including ...